Search for Clinical Trial Results

Sponsored By

Hyperparathyroidism, Secondary - 25 Studies Found

Status Study
Completed Study Name: Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide
Condition: Hyperparathyroidism, Secondary
Date: 2013-08-28
Interventions: Drug: Etelcalcetide Etelcalcetide is provided as a sterile lyophilized powder to be reconstituted with s
Completed Study Name: Safety, Tolerability and Pharmacokinetics of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Condition: Hyperparathyroidism, Secondary
Date: 2010-05-28
Interventions:
  • Drug: Saline Single IV injecti
Completed Study Name: Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis
Condition: Hyperparathyroidism, Secondary
Date: 2013-02-05
Interventions: Drug: Etelcalcetide Administered by bolus injection into the venous line of the dialysis circuit at the
Completed Study Name: Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis
Condition: Hyperparathyroidism, Secondary
Date: 2013-02-05
Interventions:
  • Drug: Etelcalcetide Administer
Completed Study Name: Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis
Condition: Hyperparathyroidism, Secondary
Date: 2013-02-07
Interventions:
  • Drug: Etelcalcetide Administer
Completed Study Name: Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis
Condition: Hyperparathyroidism, Secondary
Date: 2010-08-12
Interventions:
  • Drug: Traditional Vitamin D Therapy

Active, not recruiting Study Name: To Assess the Long-term Safety of AMG 416 in the Treatment of SHPT in Subjects With CKD on Hemodialysis
Condition: Hyperparathyroidism, Secondary
Date: 2014-03-03
Interventions: Drug: AMG 416 Subjects will be administered IV AMG 416 at the end of their regular dialysis sessions on
Completed Study Name: Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis
Condition: Secondary Hyperparathyroidism
Date: 2014-05-14
Interventions: Drug: KHK7580 Oral administration
Completed Study Name: Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism
Condition: Secondary Hyperparathyroidism
Date: 2006-03-27
Interventions: Drug: paricalcitol
Completed Study Name: A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis
Condition: Secondary Hyperparathyroidism
Date: 2014-04-29
Interventions:
  • Drug: ASP7991 oral
Next >>>